Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn.
about
Antibiotic use and misuse in the neonatal intensive care unitRisk assessment in neonatal early onset sepsisIsolated elevated blood neutrophil concentration at altitude does not require NICU admission if appropriate reference ranges are used.Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.Time for a neonatal-specific consensus definition for sepsis.Unnecessary workup of asymptomatic neonates in the era of group B streptococcus prophylaxis.Choosing the right empirical antibiotics for neonates.Epidemiological Evaluation of Blood Culture Patterns among Neonates Receiving VancomycinC-Reactive Protein, Detected with a Highly Sensitive Assay, in Non-Infected Newborns and Those with Early Onset Infection.Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at deliveryInterpreting complete blood counts soon after birth in newborns at risk for sepsis.Very late onset infections in the neonatal intensive care unit.Use of the complete blood cell count in early-onset neonatal sepsisUse of the complete blood cell count in late-onset neonatal sepsis.Reappraisal of guidelines for management of neonates with suspected early-onset sepsis.Duration of empirical antibiotic therapy for infants suspected of early-onset sepsis.Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis.Antibiotic stewardship: reassessment of guidelines for management of neonatal sepsisSerial physical examinations, a simple and reliable tool for managing neonates at risk for early-onset sepsis.2010 perinatal GBS prevention guideline and resource utilization.Clinical and microbiological profile of babies born with risk of neonatal sepsisGene expression profiling at birth characterizing the preterm infant with early onset infection.Clinical chorioamnionitis at term VI: acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity.Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies.Emerging Technologies for Molecular Diagnosis of Sepsis.Management of term infants at increased risk for early-onset bacterial sepsis.La prise en charge des nouveau-nés à terme à risque de sepsis bactérien d’apparition précoce.
P2860
Q27003877-E40A99FB-10DF-4364-9948-B2C561DB3B43Q27026247-4D0AAF91-219C-4567-BE0E-F0AB4487155AQ33384186-D9C8AF58-85F3-466A-B3F6-B0E8A98AC93DQ33568561-DACFB8C3-307B-4539-A6F3-5049EA587D5AQ33864692-1D4CD76D-B35A-472C-B194-188585D8EB3BQ34106044-2E5E8FF2-5313-4C63-BCE5-B9C73DBF846EQ34138000-837AAE96-1C1A-4655-A49C-6833C84E116EQ34294765-5D88674E-25C2-421B-8A9D-20D115E1CFD3Q34870402-95E3714B-2609-421C-A052-C12E35324CE3Q35131152-298BF150-75FF-4D9D-81E0-70297B429798Q35401811-036E3E33-00C8-4E1B-B9BA-74BD7366FF56Q35643346-EBFDE42B-D8D9-4A20-BF98-2E82E7B434AAQ36103569-3604EA59-5C77-4B73-B42E-6B5F757C2C6EQ36103605-724907F6-610A-4CE7-828F-C6BCD859F03BQ36617534-E86851AF-74ED-4025-A19B-E3653DC0052EQ36681044-1FBA5A74-2538-4AC0-886A-733A7585014AQ36763507-12357119-1FC5-4144-B410-56A715B753DFQ36955843-FBD80F53-943B-4378-A3C9-7413F3E64076Q37399655-10E6A03E-E82E-4E7C-BDFF-1F9357842C17Q37522924-6A379E83-D3EB-4CE6-9BA9-196EDA60154BQ37581939-5BEAD42A-BE61-40A0-86C2-6C15DA0121DEQ37588629-2216B266-936B-45B7-96AF-53E0C44EA14BQ41008958-9B66DED4-2F50-4BB7-A7C0-DE4E51F57F1AQ47146605-2E0F973A-FCA8-40E7-AE55-2F282160549EQ50421514-DCD68E67-0405-472A-A103-5F74F3BEF4D5Q52685404-53152D97-B3E3-4741-917C-D41FB5772382Q55350082-0FC962DA-1AE2-452B-AF19-D126C55850FD
P2860
Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Utility of complete blood coun ...... asymptomatic at risk newborn.
@ast
Utility of complete blood coun ...... asymptomatic at risk newborn.
@en
type
label
Utility of complete blood coun ...... asymptomatic at risk newborn.
@ast
Utility of complete blood coun ...... asymptomatic at risk newborn.
@en
prefLabel
Utility of complete blood coun ...... asymptomatic at risk newborn.
@ast
Utility of complete blood coun ...... asymptomatic at risk newborn.
@en
P2093
P1476
Utility of complete blood coun ...... asymptomatic at risk newborn.
@en
P2093
Kathleen Lundgren
Laura J Mirkinson
Martin G Ottolini
Mary C Ottolini
Sheila Cason
P304
P356
10.1097/00006454-200305000-00008
P577
2003-05-01T00:00:00Z